Skip to content

Other

Terbutaline sulfate [USAN:JAN]

CAS 23031-32-5
18

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A beta-2 adrenergic bronchodilator drug used to treat asthma and COPD. Labelled with H361 (suspected reproductive toxicity) and is not permitted in cosmetic formulations under EU cosmetics law.

Terbutaline sulfate is a synthetic catecholamine that acts primarily on beta-2 receptors to relax bronchial smooth muscle. It carries the GHS signal word 'Warning' and hazard H361 (suspected reproductive toxicity). EU cosmetics regulation does not permit bronchodilator drugs as cosmetic ingredients; they are regulated as medicinal products.

Known concerns

  • H361 — suspected reproductive toxicity
  • EU regulated as medicinal substance, not cosmetics ingredient
  • Cardiovascular effects (tachycardia, palpitations)
  • Neurological effects possible

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find Terbutaline sulfate [USAN:JAN] in your products.

Scan any cosmetic product with LuxSense to see if it contains Terbutaline sulfate [USAN:JAN] and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.